ALFA Finder| Revenue growth | FY26 revenue ₹67,137 million; Q4 showed sequential growth. |
|---|---|
| Margins | Gross margin at 58%; EBITDA margin resilient at 25%. |
| Order book | CSM order book remains steady at $1.1-1.2 billion. |
| Demand visibility | Expect recovery in H2 FY27; domestic momentum tied to Kharif. |
| Management confidence | High confidence in NCE transition and Pharma CRDMO scale-up. |
Growth
FY26 revenue at ₹67,137M; Pharma segment grew 40% YoY. Q4 revenue reached ₹15,652M with sequential growth.
Outlook
Guidance for positive FY27 growth led by NCE launch and Pharma scale-up. FY27 capex planned at ₹700-800cr.
Risks
Global AgChem downcycle, uneven recovery, Middle East conflict disruptions, and high channel inventory in domestic markets.
Earnings Call filed with NSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹1,714.80
- Market cap
- ₹26,017 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 29.6×Sector 35.1×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Earnings Call Transcript: Key Takeaways
PI Industries faces severe headwinds in its core AgChem export business, masking strong domestic and biological growth.
PI Industries Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue fell 9% to INR17,018Mn, EBITDA margin compressed to 14%, and PAT fell 70%. Domestic and Biologicals grew; agchem exports declined 18%.
PI Industries Q2 FY27 Results: Net Profit ₹122.2 Cr, Down 70.1% YoY
PI Industries Ltd reported revenue from operations of ₹1,702 Cr (-9.1% YoY) and net profit of ₹122.2 Cr (-70.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹122.2 Cr · -70.1% YoY
PI Industries Business Update
PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule, which has received CIB&RC registration. The press release marks a milestone in the company's original crop-protection research.
PI Industries Board Meeting Date
PI Industries has intimated a board meeting on November 4, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window is closed from October 1 to November 6, 2026.
PI Industries Other Announcement
PI Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations. This is a routine regulatory compliance filing.